Cited by 3,125Heart Failure Treatment and ManagementElectrolyte and hormonal disordersCardiac Fibrosis and Remodeling

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Cohn, Jay N., Levine, T. Barry, Olivari, Maria Teresa, Garberg, Victoria, Lura, Dennis, Francis, Gary S., Simon, Ada B., Rector, Thomas·1984·New England Journal of Medicine

DOI 10.1056/nejm198409273111303

Open this paper in CoChat — free account

Abstract

Hemodynamics, plasma norepinephrine, and plasma renin activity were measured at supine rest in 106 patients (83 men and 23 women) with moderate to severe congestive heart failure. During follow-up lasting 1 to 62 months, 60 patients died (57 per cent); 47 per cent of the deaths were sudden, and 45 per cent were related to progressive heart failure. Statistically unrelated to the risk of mortality were cause of disease (60 patients had coronary disease, and 46 had cardiomyopathy), age (mean, 54.8 years), cardiac index (mean, 2.11 liters per minute per square meter of body-surface area), pulmonary wedge pressure (mean, 24.5 mm Hg), and mean arterial pressure (mean, 83.2 mm Hg). A multivariate analysis of the five significant univariate prognosticators--heart rate (mean, 84.4 beats per minute), plasma renin activity (mean, 15.4 ng per milliliter per hour), plasma norepinephrine (mean, 700 pg per milliliter), serum sodium (mean, 135.7 mmol per liter), and stroke-work index (mean, 21.0 g-meters per square meter)--found only plasma norepinephrine to be independently (P = 0.002) related to the subsequent risk of mortality. Norepinephrine was also higher in patients who died from progressive heart failure than in those who died suddenly. These data suggest that a single resting venous blood sample showing the plasma norepinephrine concentration provides a better guide to prognosis than other commonly measured indexes of cardiac performance.

Integrity signals

Registry

Crossref · 10.1056/nejm198409273111303

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 925
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citation
Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man
Lake, C., Ziegler, M. G., & Kopin, I. J. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90210-1 · Cited by 548
Determinants of Survival in Patients with Ventricular Tachyarrhythmias
Swerdlow, C. D., Winkle, R. A., & Mason, J. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082402 · Cited by 508
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart Failure
Chidsey, C. A., Harrison, D. C., & D, E. B. M. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 439

Show all 23 references

Research works printed but not linked: 2

Hopkins A. Survival analysis with covariates — Cox models. In: BMDP statistical software. Berkeley, Calif.: University of California Press, 1983: 576–94.
10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 301–400 of 1,002

Mechanisms and Clinical Consequences of Untreated Central Sleep Apnea in Heart Failure
Costanzo, M. R., Khayat, R., Ponikowski, P. P., Augostini, R. S., Stellbrink, C., Mianulli, M. J., & Abraham, W. T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.025 · Cited by 153
Regulation of the mRNA-binding Protein AUF1 by Activation of the β -Adrenergic Receptor Signal Transduction Pathway
Pende, A., Tremmel, K. D., DeMaria, C. T., Blaxall, B. C., Minobe, W. A., Sherman, J. A., Bisognano, J. D., Bristow, M. R., Brewer, G., & Port, J. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8493 · Cited by 149
Association of a Serotonin Transporter Polymorphism (5-HTTLPR) With Depression, Perceived Stress, and Norepinephrine in Patients With Coronary Disease: The Heart and Soul Study
Otte, C., McCaffery, J. M., Ali, S., & Whooley, M. A. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101617 · Cited by 146
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker, L. E., Noll, G., Ruschitzka, F. T., & Lüscher, T. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01210-4 · Cited by 150
Insights into the contemporary epidemiology and outpatient management of congestive heart failure
McAlister, F. A., Teo, K. K., Taher, M., Montague, T. J., Humen, D. P., Cheung, L. K., Kiaii, M., Yim, R., & Armstrong, P. W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70251-6 · Cited by 144
Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.
OʼConnell, J. B., Bourge, R. C., Costanzo-Nordin, M. R., Driscoll, D. J. O., Morgan, J. P., Rose, E. A., & Uretsky, B. F. (1992) · Circulation · doi:10.1161/01.cir.86.3.1061 · Cited by 148
Beta-Adrenergic Receptors, from Their Discovery and Characterization through Their Manipulation to Beneficial Clinical Application
Wachter, S. B., & Gilbert, E. M. (2012) · Cardiology · doi:10.1159/000339271 · Cited by 147
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4
Backs, J., Worst, B. C., Lehmann, L., Patrick, D. M., Jebessa, Z. H., Kreußer, M. M., Sun, Q., Chen, L., Heft, C., Katus, H. A., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105063 · Cited by 148
Relation of daily activity levels in patients with chronic heart failure to long-term prognosis
Walsh, J. T., Charlesworth, A., Andrews, R. V., Hawkins, M., & Cowley, A. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00141-0 · Cited by 145
Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure
Dibner‐Dunlap, M. E., Smith, M. L., Kinugawa, T., & Thames, M. D. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00484-x · Cited by 143
Noninvasive Ventilation
Hillberg, R. E., & Johnson, D. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372407 · Cited by 147
Mechanical Circulatory Support and Cardiac Transplantation
Hunt, S. A., & Frazier, O. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2079 · Cited by 146
Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity
Mansfield, D. R., Kaye, D. M., Rocca, H. B., Solin, P., Esler, M., & Naughton, M. T. (2003) · Circulation · doi:10.1161/01.cir.0000056520.17353.4f · Cited by 146
Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure
Grossman, E., & Messerli, F. H. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00722-4 · Cited by 145
Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure
Boomsma, F. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00209-x · Cited by 145
Functional disorders of the sympathetic nervous system in mice lacking the α 1B subunit (Ca v 2.2) of N-type calcium channels
Ino, M., Yoshinaga, T., Wakamori, M., Miyamoto, N., Takahashi, E., Sonoda, J., Kagaya, T., Oki, T., Nagasu, T., Nishizawa, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081089398 · Cited by 144
Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta,- and beta2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease
Brodde, O., Zerkowski, H., Doetsch, N., Motomura, S., Khamssi, M., & Michel, M. C. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90181-2 · Cited by 144
Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy
Wisenbaugh, T. W., Katz, I. J., Davis, J., Essop, R., Skoularigis, J. S., Middlemost, S. J., Röthlisberger, C., Skudicky, D., & Sareli, P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90230-x · Cited by 144
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Lyngbakken, M. N., Myhre, P. L., Røsjø, H. R., & Omland, T. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1525335 · Cited by 155
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Mathai, S. C., Bueso, M., Hummers, L. K., Boyce, D. M., Lechtzin, N., Pavec, J. L., Campo, A., Champion, H. C., Housten, T., Forfia, P. R., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00074309 · Cited by 142
Combined Oral Positive Inotropic and Beta-Blocker Therapy for Treatment of Refractory Class IV Heart Failure
Shakar, S. F., Abraham, W. T., Gilbert, E. M., Robertson, A. D., Lowes, B. D., Zisman, L. S., Ferguson, D. A., & Bristow, M. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00077-1 · Cited by 141
Akt Mediates the Cross-Talk Between β-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes
Morisco, C., Condorelli, G., Trimarco, V., Bellis, A., Marrone, C., Condorelli, G., Sadoshima, J., & Trimarco, B. (2005) · Circulation Research · doi:10.1161/01.res.0000152968.71868.c3 · Cited by 141
1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload
O’Connell, T. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 143
Association of Anhedonia With Recurrent Major Adverse Cardiac Events and Mortality 1 Year After Acute Coronary Syndrome
Davidson, K. W., Burg, M. M., Kronish, I. M., Shimbo, D., Dettenborn, L., Mehran, R., Vorchheimer, D. A., Clemow, L., Schwartz, J. E., & Rieckmann, N. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.36 · Cited by 141
Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms
Li, Y., & Patel, K. P. (2002) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01043.x · Cited by 140
Prognostic Value of Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Idiopathic or Ischemic Dilated Cardiomyopathy
Szabó, B. M., van Veldhuisen, D. J., van der Veer, N., Brouwer, J., de Graeff, P. A., & Crijns, H. J. G. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00026-x · Cited by 140
Exercise Training Reduces Sympathetic Nerve Activity in Heart Failure Patients Treated with Carvedilol
Fraga, R. F., Franco, F. G. M., Roveda, F., de Matos, L. D. N. J., Braga, A., Rondon, M. U. P. B., Rotta, D. R., Brum, P. C., Barretto, A. C. P., Middlekauff, H. R., et al. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.03.003 · Cited by 136
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol
Lowes, B. D., Tsvetkova, T. O., Eichhorn, E. J., Gilbert, E. M., & Bristow, M. R. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00520-4 · Cited by 139
Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation.
Mortara, A., Rovere, M. T. L., Signorini, M. G., Pantaleo, P., Pinna, G. D., Martinelli, L., Ceconi, C., Cerutti, S., & Tavazzi, L. (1994) · Heart · doi:10.1136/hrt.71.5.422 · Cited by 139
Cardioprotection for Duchenne’s muscular dystrophy
Ishikawa, Y., Bach, J. R., & Minami, R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70414-x · Cited by 139
Renal and circulatory mechanisms in congestive heart failure
Dzau, P. D. V. J. (1987) · Kidney International · doi:10.1038/ki.1987.156 · Cited by 139
??-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure
Kaye, D. M., Smirk, B., Williams, C., Jennings, G., Esler, M., & Holst, D. (2003) · Pharmacogenetics · doi:10.1097/00008571-200307000-00002 · Cited by 138
Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction
McGhie, A. I., Corbett, J. R., Akers, M. S., Kulkarni, P., Sills, M. N., Kremers, M. S., Buja, L. M., Durant-Reville, M., Parkey, R. W., & Willerson, J. T. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90552-v · Cited by 138
Electrophysiological effects of acute ventricular dilatation in the isolated rabbit heart.
Reiter, M. J., Synhorst, D. P., & Mann, D. E. (1988) · Circulation Research · doi:10.1161/01.res.62.3.554 · Cited by 138
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
Böhm, M., Morano, I. L., Pieske, B. M., Rüegg, J. C., Wankerl, M., Zimmermann, R., & Erdmann, E. (1991) · Circulation Research · doi:10.1161/01.res.68.3.689 · Cited by 138
Multimodality Cardiovascular Molecular Imaging, Part II
Nahrendorf, M., Sosnovik, D. E., French, B. A., Świrski, F. K., Bengel, F. M., Sadeghi, M. M., Lindner, J. R., Wu, J. C., Kraitchman, D. L., Fayad, Z. A., et al. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.839092 · Cited by 138
Real-time optical recording of β1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol
Rochais, F., Vilardaga, J., Nikolaev, V. O., Bünemann, M., Lohse, M. J., & Engelhardt, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30012 · Cited by 137
Regulation of beta-adrenoceptor signaling in cardiac function and disease.
Dzimiri, N. (1999) · PubMed · Cited by 137
Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure
Dimopoulos, S. K., ANASTASIOU‐NANA, M. I., Sakellariou, D., Drakos, S. G., Kapsimalakou, S., Maroulidis, G., Roditis, P., Papazachou, O., Vogiatzis, I., Roussos, C., et al. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000198449.20775.7c · Cited by 136
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I
Piepoli, M. F., Guazzi, M., Boriani, G., Cicoira, M., Corrà, U., Libera, L. D., Emdin, M., Mele, D., Passino, C., Vescovo, G., et al. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283361dc5 · Cited by 137
Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise
Notarius, C. F., Atchison, D. J., & Floras, J. S. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h969 · Cited by 136
Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia
Shusterman, V., Aysin, B., Gottipaty, V. K., Weiss, R., Brode, S., Schwartzman, D. A., & Anderson, K. P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00468-9 · Cited by 136
Bisoprolol dose–response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study (CIBIS II)
Simon, T. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00743-1 · Cited by 136
Ca2+ currents in compensated hypertrophy and heart failure
Richard, S. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00273-3 · Cited by 136
Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure
Kaye, D. M., Vaddadi, G., Gruskin, S., Du, X., & Esler, M. (2000) · Circulation Research · doi:10.1161/01.res.86.7.e80 · Cited by 136
Role of Paraventricular Nucleus in Mediating Sympathetic Outflow in Heart Failure
Patel, K. P. (2000) · Heart Failure Reviews · doi:10.1023/a:1009850224802 · Cited by 136
Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy
Moruzzi, P., Doria, E., & Agostoni, P. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00281-1 · Cited by 135
The Search for Trans-Acting Factors Controlling Messenger RNA Decay
Wilson, G. M., & Brewer, G. (1998) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60510-3 · Cited by 135
Abnormal neurovascular control during exercise is linked to heart failure severity
Negrão, C. E., Rondon, M. U. P. B., Tinucci, T., Alves, M. J. N. N., Roveda, F., Braga, A. M. W., Reis, S. F., Nastari, L., Barretto, A. C. P., Krieger, E. M., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h1286 · Cited by 135
Pathophysiological Role of Cytokines in Congestive Heart Failure
Blum, A., & Miller, H. I. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.15 · Cited by 135
Short- and long-term neurohormonal activation following acute myocardial infarction
Sigurðsson, A. F., Held, P. H., & Swedberg, K. B. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90656-t · Cited by 134
Inotropes in the management of acute heart failure
Petersen, J. W., & Felker, G. M. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000296273.72952.39 · Cited by 133
Plasma norepinephrine levels in infants and children with congestive heart failure
Ross, R. D., Daniels, S. R., Schwartz, D. C., Hannon, D. W., Shukla, R., & Kaplan, S. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91118-0 · Cited by 132
Propranolol Prevents the Development of Heart Failure by Restoring FKBP12.6-Mediated Stabilization of Ryanodine Receptor
Doi, M., Yano, M., Kobayashi, S., Kohno, M., Tokuhisa, T., Okuda, S., Suetsugu, M., Hisamatsu, Y., Ohkusa, T., Kohno, M., et al. (2002) · Circulation · doi:10.1161/hc1102.105270 · Cited by 132
Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart Disease
Ohuchi, H., Takasugi, H., Ohashi, H., Okada, Y., Yamada, O., Ono, Y., Yagihara, T., & Echigo, S. (2003) · Circulation · doi:10.1161/01.cir.0000101681.27911.fa · Cited by 132
Metoprolol controlled release/extended release in patients with severe heart failure
Goldstein, S., Fagerberg, B., Hjalmarson, Å. C., KJEKSHUS, J. K., Waagstein, F., Wedel, H., & Wikstrand, J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01516-9 · Cited by 132
Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
Grassi, G. M. (2006) · Hypertension Research · doi:10.1291/hypres.29.839 · Cited by 131
Sympathetic activation: a potential link between comorbidities and COVID‐19
Porzionato, A., Emmi, A., Barbon, S., Rafael Boscolo-berto, A., Stecco, C., Stocco, E., Macchi, V., & De, R. (2020) · FEBS Journal · doi:10.1111/febs.15481 · Cited by 132
Regulation of glomerular filtration rate in chronic congestive heart failure patients
Cody, R. J., Ljungman, S., Covit, A. B., Kubo, S. H., Sealey, J. E., Pondolfino, K., Clark, M. A., James, G. D., & Laragh, J. H. (1988) · Kidney International · doi:10.1038/ki.1988.189 · Cited by 130
Effects of pharmacological adrenergic and vagal modulation on fractal heart rate dynamics
Tulppo, M. P., Mäkikallio, T. H., Seppänen, T., Shoemaker, J. K., Tutungi, E., Hughson, R. L., & Huikuri, H. V. (2001) · Clinical Physiology · doi:10.1046/j.1365-2281.2001.00344.x · Cited by 129
Sudden Cardiac Death in Heart Failure
Marbán, E., & Tomaselli, G. F. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_40 · Cited by 130
Prognostic significance of cardiac 123I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study
Ogita, H., Shimonagata, T., Fukunami, M., Kumagai, K., Yamada, T., Asano, Y., Hirata, A., Asai, M., Kusuoka, H., Hori, M., et al. (2001) · Heart · doi:10.1136/heart.86.6.656 · Cited by 128
Biomarkers in heart failure: the past, current and future
Michael, S., Wang, Y., Wei, J., Huang, Y., Li, M., Li, L., Acheampong, E., Zhou, Z., Xiaoyan, Q., Xu, Y., et al. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09807-z · Cited by 128
Congenital heart disease: the original heart failure syndrome
Bolger, A. P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00005-8 · Cited by 128
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives
Kjær, A., & Hesse, B. (2001) · Clinical Physiology · doi:10.1046/j.1365-2281.2001.00371.x · Cited by 129
CA 125 and its relation to cardiac function
Nägele, H., Bahlo, M., Klapdor, R., Schaeperkoetter, D., & Rödiger, W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70360-1 · Cited by 127
Inhibition of receptor-localized PI3K preserves cardiac β-adrenergic receptor function and ameliorates pressure overload heart failure
Nienaber, J. J., Tachibana, H., Prasad, S. V. N., Esposito, G., Wu, D., Mao, L., & Rockman, H. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18213 · Cited by 127
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure
Hirsch, A. T., Pinto, Y. M., Schunkert, H., & Dzau, V. J. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90473-e · Cited by 126
Carotid Body Resection for Sympathetic Modulation in Systolic Heart Failure: Results from First-In-Man Study
Niewiński, P., Janczak, D., Ruciński, A., Tubek, S., Engelman, Z. J., Piesiak, P., Jaźwiec, P., Banasiak, W., Fudim, M., Sobotka, P. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.641 · Cited by 126
Left ventricular hypertrophy in renal failure
Amann, K., Rychlík, I., Miltenberger-Miltény, G., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06818.x · Cited by 126
Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.10.005 · Cited by 125
Predictors of prognosis in patients with stable mild to moderate heart failure
Bettencourt, P., Ferreira, A., Dias, P., Pimenta, J. M., Friões, F., Martins, L., & Cerqueira-Gomes, M. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.20558 · Cited by 125
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure
Fisher, C., Berry, C., Blue, L., Morton, J. J., & McMurray, J. J. V. (2003) · Heart · doi:10.1136/heart.89.8.879 · Cited by 125
Prognostic importance of the serum magnesium concentration in patients with congestive heart failure
Gottlieb, S. S., Baruch, L., Kukin, M. L., Bernstein, J. L., Fisher, M. L., & Packer, M. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80329-8 · Cited by 125
Why has Positive Inotropy Failed in Chronic Heart Failure? Lessons from Prior Inotrope Trials
Ahmad, T., Miller, P. E., McCullough, M., Desai, N. R., Riello, R. J., Psotka, M. A., Böhm, M., Allen, L. A., Teerlink, J. R., Rosano, G. M. C., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1557 · Cited by 124
Epidemiology, Pathophysiology, Prognosis, and Treatment of Systolic and Diastolic Heart Failure
Aronow, W. S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000175289.87583.e5 · Cited by 124
Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies
O'Brien, P. J., Ianuzzo, C. D., Moe, G. W. P. L., Stopps, T. P., & Armstrong, P. W. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-004 · Cited by 124
SLEEP APNEA IN CONGESTIVE HEART FAILURE
Naughton, M. T., & Bradley, T. D. (1998) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70435-4 · Cited by 124
Sodium Retention in Heart Failure and Cirrhosis
Bansal, S., Lindenfeld, J. M., & Schrier, R. W. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.821199 · Cited by 124
Remodeling of Calcium Handling in Human Heart Failure
Lou, Q., Janardhan, A. H., & Efimov, I. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_52 · Cited by 123
Autonomic function and rheumatoid arthritis—A systematic review
Adlan, A., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.06.003 · Cited by 122
Effects of Selective Autonomic Blockade on T-Wave Alternans in Humans
Rashba, E. J., Cooklin, M., MacMurdy, K., Kavesh, N. G., KIRK, M. M., Sarang, S., Peters, R. W., Shorofsky, S. R., & Gold, M. R. (2002) · Circulation · doi:10.1161/hc0702.104127 · Cited by 122
Novel therapeutic approaches for heart failure by normalizing calcium cycling
Wehrens, X. H. T., & Marks, A. R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1440 · Cited by 122
Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure
Kaye, D. M., Mansfield, D. R., Aggarwal, A., Naughton, M. T., & Esler, M. (2001) · Circulation · doi:10.1161/01.cir.103.19.2336 · Cited by 121
RIGHT AND LEFT VENTRICULAR FUNCTIONAL IMPAIRMENT AND SLEEP APNEA
Bradley, T. D. (1992) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00874-1 · Cited by 122
Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure
Jensen, B. C., O’Connell, T. D., & Simpson, P. C. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.014 · Cited by 121
Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors
Gheorghiade, M., Hall, V. B., Jacobsen, G., Alam, M., Rosman, H., & Goldstein, S. (1995) · Circulation · doi:10.1161/01.cir.92.7.1801 · Cited by 121
Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome
Grassi, G. M., Seravalle, G., Quarti‐Trevano, F., Scopelliti, F., Dell’Oro, R., Bolla, G. B., & Mancia, G. (2007) · Hypertension · doi:10.1161/01.hyp.0000255983.32896.b9 · Cited by 121
Adaptations in autonomic function during exercise training in heart failure
Negrão, C. E., & Middlekauff, H. R. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9057-7 · Cited by 121
Spectrum and outcome of congestive heart failure in a hospitalized population
Andersson, B., & Waagstein, F. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90414-5 · Cited by 121
Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats
Xiao, D., Dasgupta, C., Chen, M., Zhang, K., Buchholz, J. N., Xu, Z., & Zhang, L. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt264 · Cited by 121
Autoantibodies Against the β1adrenoceptor from Patients with Dilated Cardiomyopathy Prolong Action Potential Duration and Enhance Contractility in Isolated Cardiomyocytes
Christ, T., Wettwer, E., Dobrev, D., Adolph, E., Knaut, M., Wallukat, G., & Ravens, U. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1414 · Cited by 120
Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens
Johanssona, M., Herlitzb, H., Jensenb, G., Rundqvist, B., & Friberga, P. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917120-00012 · Cited by 120
Comprehensive Local Muscle Training Increases Aerobic Working Capacity and Quality of Life and Decreases Neurohormonal Activation in Patients with Chronic Heart Failure
Tyni‐Lenné, R., Dencker, K., Gordon, A., Jansson, E., & Sylvén, C. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00087-8 · Cited by 120
Nuclear α1-Adrenergic Receptors Signal Activated ERK Localization to Caveolae in Adult Cardiac Myocytes
Wright, C. D., Chen, Q., Baye, N. L., Huang, Y., Healy, C. L., Kasinathan, S., & O’Connell, T. D. (2008) · Circulation Research · doi:10.1161/circresaha.108.176024 · Cited by 120
Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure
Moe, G. W. P. L., Stopps, T. P., Angus, C., Förster, C., Bold, A. J. D., & Armstrong, P. W. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90567-6 · Cited by 120
Type D personality is associated with increased levels of tumour necrosis factor (TNF)-α and TNF-α receptors in chronic heart failure
Conraads, V. M., Denollet, J., De Clerck, L. S., Stevens, W. J., Bridts, C., & Vrints, C. J. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.10.013 · Cited by 119
A perspective on the muscle reflex: implications for congestive heart failure
Sinoway, L. I., & Li, J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01405.2004 · Cited by 119
G Protein Coupled Receptor Kinases as Therapeutic Targets in Cardiovascular Disease
Belmonte, S. L., & Blaxall, B. C. (2011) · Circulation Research · doi:10.1161/circresaha.110.231233 · Cited by 119
Elevation of plasma neuropeptide Y levels in congestive heart failure
Maisel, A. S., Scott, N. A., Motulsky, H. J., Michel, M. C., Boublik, J. H., Rivier, J., Ziegler, M. G., Allen, R. S., & Brown, M. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90228-3 · Cited by 119

Authors: Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1984-09-27
Volume: 311
Issue: 13
Pages: 819-823
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm198409273111303
OpenAlex: W2338638760
Cited by: 3,125
References: 23
Citations by year: 2026: 22 · 2025: 30 · 2024: 22 · 2023: 44 · 2022: 50 · 2021: 49 · 2020: 54 · 2019: 58 · 2018: 42 · 2017: 57 · 2016: 75 · 2015: 73 · 2014: 101 · 2013: 87 · 2012: 88
FWCI: 34.36
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords: plasma norepinephrine, congestive heart failure, prognosis, mortality risk, plasma renin activity, hemodynamics, sudden death, progressive heart failure, prognostic factors, heart rate, stroke work index, serum sodium
MeSH terms: Age Factors, Blood Pressure, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hemodynamics, Humans, Male, Middle Aged, Norepinephrine, Prognosis, Pulmonary Wedge Pressure, Renin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks